Current Issue Table of Contents: European Journal of Surgical Oncology
PDF) Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar
Surgical Oncology | Rutgers Cancer Institute of New Jersey
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Liver metastasectomy-cytoreductive surgery- hyperthermic intraperitoneal chemotherapy and ileal pouch-anal anastomosis: A case report - ScienceDirect
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Annals of Surgical Oncology 1/2016 | springermedizin.de
hipec - YouTube
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Survival results in 49 patients after HIPEC (hyperthermic... | Download Scientific Diagram
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
AIS Channel
Complications after CRS and HIPEC | Download Table
Ioannis D. Kyriazanos - Clinical Oncology Journal (ISSN 2766-9882)
